Type: announcement

Stripe's planned acquisition of OpenRouter for approximately $7.5 billion marks a significant move into the artificial intelligence sector, aiming to enhance its offerings in AI model optimization and cost management for businesses.

The Treasury Department and IRS have proposed new rules that could disqualify many immigrants from accessing refundable tax credits, potentially affecting millions of lower-income individuals. This move aligns with the Trump administration's broader strategy to tighten immigration policies through financial regulations.

Treasury Secretary Scott Bessent's decision to increase buybacks of long-term Treasury debt aims to lower yields, but it complicates the Federal Reserve's monetary policy and raises concerns about inflation and government borrowing costs.

OpenAI's CFO Sarah Friar announced that the company plans to go public in 2027, with the possibility of an earlier IPO depending on business performance, which is significant for investors monitoring the AI sector's growth and competition.

The Department of Justice is pushing to maintain criminal charges against former FBI director James Comey, arguing that his Instagram post featuring seashells arranged as '86 47' could be interpreted as a threat against President Trump. This case highlights the contentious relationship between Comey and Trump, and the implications of political speech in legal contexts.

President Trump's announcement of a temporary deal with Canada to postpone significant tariffs on Canadian goods highlights ongoing trade negotiations that could impact U.S.-Canada relations and various industries reliant on cross-border trade.

The approval of a $19.9 billion overhaul plan for Washington Dulles Airport is significant as it aims to modernize infrastructure and improve passenger transport efficiency, which could enhance the airport's competitiveness and service quality in the long term.

Marvell Technology's shares surged 6% following a significant agreement allowing Google to purchase up to $12.2 billion in shares, highlighting the growing collaboration between the two companies in the AI chip sector.

BioMarin Pharmaceutical's acquisition of Alesta Therapeutics for $275 million marks a strategic move to enhance its portfolio in rare diseases, particularly targeting hypophosphatasia (HPP). This deal underscores BioMarin's commitment to addressing unmet medical needs in the rare disease market.

Cantor Fitzgerald's partnership with Kalshi marks a significant step in bringing institutional trading to prediction markets, potentially increasing liquidity and participation from large investors in this emerging asset class.